检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:诸葛宇征[1] ZHUGE Yuzheng(Department of Gastroenterology,Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School,Nanjing 210008,China)
机构地区:[1]南京大学医学院附属南京鼓楼医院消化内科,南京210008
出 处:《临床肝胆病杂志》2024年第1期10-12,共3页Journal of Clinical Hepatology
摘 要:非肝硬化内脏静脉血栓(NC-SVT)主要包括门静脉血栓、肠系膜上静脉血栓、脾静脉血栓和肝静脉血栓(布加综合征),其患病率随着相关基础疾病发病率升高而呈现上升趋势。由于NC-SVT严重的危害性,临床医生对其诊断意识和诊断能力也明显提高。但在治疗上往往只重视抗凝、介入等针对血栓的处理,而忽视对导致SVT的危险因素或基础疾病的筛查,一定程度上影响部分患者的血栓治疗效果,也将延误对基础疾病的诊断和治疗。本文简要介绍了与NC-SVT发生相关的获得性、遗传性及系统性、局部性基础疾病。Non-cirrhotic splanchnic vein thrombosis(NC-SVT)mainly includes portal vein thrombosis,superior mesenteric vein thrombosis,splenic vein thrombosis,and hepatic vein thrombosis(Budd-Chiari syndrome),and its prevalence rate is increasing with the increase in the incidence rates of related underlying diseases.Due to the harm of NC-SVT,there have been significant improvements in the awareness and ability for diagnosis among clinicians.However,anticoagulation and intervention therapies for thrombosis are often taken seriously in treatment,while the screening for risk factors or underlying diseases leading to SVT is ignored,which may affect the treatment outcome of thrombus in some patients and delay the diagnosis and treatment of the underlying disease.This article mainly introduces the acquired,hereditary,systemic,and local underlying diseases associated with the development of NC-SVT.
分 类 号:R543.6[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7